Trusted Resources: People & Places

Online groups, photo galleries and blogs

Back to People / Researchers

Julie Eisengart, PhD, LP

Associate Professor
Department of Pediatrics
University of Minnesota
100 Church Street SE
Minneapolis, Minnesota, United States

Dr. Julie Eisengart is an Associate Professor in the Department of Pediatrics and the Director of the Neurodevelopmental Program in Rare Disease. As a Pediatric Neuropsychologist, she specializes in rare neurodegenerative disorders of childhood as well as a range of complex medical conditions, and she works with patients from infancy to young adulthood. Her clinical interests include assessing the strengths and needs of children affected by complex medical diagnoses, throughout their medical journeys, to optimize whole-child, whole-family care and supports. As a clinical supervisor and mentor, she values her role in training future psychologists and supporting their development into independent, balanced professionals.

Dr. Eisengart’s research interests include lysosomal storage disorders like Mucopolysaccharidosis (MPS), natural histories and treatment outcomes of rare diseases involving the central nervous system. She focuses on the changing relationships between brain structure, biochemical abnormalities, and brain function in rare disease, with the goal of predicting outcomes and improving supportive planning. She has been heavily involved in examining outcomes of early diagnosis, newborn screening, and/or novel therapies for rare disease. Her research extends to defining and measuring aspects of disease that are under-represented in the clinical and research communities but are important and meaningful to patients and their families, such as neurobehavioral symptoms and the caregiver lived experience.


Representative Publications:

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

The Natural History of Neurocognition in MPS Disorders: A Review

Issues of COVID-19-Related Distance Learning for Children With Neuronopathic Mucopolysaccharidoses